Massachusetts H 1137: An Act relative to cancer patient access to biomarker testing to provide appropriate therapy

Status: Accompanied a study order, see H5222 (as of 2022-09-15)

State: Massachusetts · Session: 192nd · Bill: H 1137

Sponsors: Meghan Kilcoyne, Carmine Lawrence Gentile, Christopher Hendricks, David Allen Robertson, James K. Hawkins, Jessica Ann Giannino, Natalie M. Higgins, Patricia A. Duffy

View Massachusetts H 1137 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.